The gene expression of CD31, NG2 and PDGFR-β was evaluated by RT-qPCR in tumor samples (Fig. 2a) and was found to vary among subjects, although it was possible to observe that certain expressions changed together. This evidence concerns the gene PECAM1 and neoplasm.